OUR SCIENCE
InxMed translates unmet medical needs into breakthrough therapies. Grounded in disease biology and driven by translational research, we develop innovative treatments that target the essential survival mechanisms of tumors.
Learn MorePIPELINE
InxMed has developed a highly differentiated portfolio of novel therapies that target key nodes across the entire tumor defense network,from the cell membrane to the nucleus,using diverse modalities including small molecules, antibodies, and ADCs. This broad target coverage and therapeutic versatility enable us to pursue fundamental solutions aimed at improving efficacy and extending survival for patients across a wide range of cancer types.
Learn More
PARTNERSHIPS
To win the battle against cancer, rationalized combination therapy is essential. InxMed is committed to developing highly efficacious yet safer treatment regimens. Achieving this goal requires strategic collaboration, and we actively seek co-development and strategic business opportunities,especially in clinical combinations and the licensing of RAS pathway inhibitors and ADCs. Grounded in a deep understanding of disease biology, we aim to deliver revolutionary, breakthrough therapies.
Learn More
LATEST NEWS
Press Release
Media Coverage
QUICK LINKS
CONTACT US
Tel: +86 25-58251030
Email: office@inxmed.com
Office address: 73 Tanmi Road Block D-2, 3rd Floor Jiangbei New District, Nanjing
MESSAGE